CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $339,864 | -40.6% | 202,300 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $572,509 | -42.4% | 202,300 | 0.0% | 0.01% | -40.0% |
Q1 2023 | $993,293 | -54.3% | 202,300 | 0.0% | 0.01% | -56.5% |
Q4 2022 | $2,172,702 | +8.4% | 202,300 | -5.5% | 0.02% | 0.0% |
Q3 2022 | $2,005,000 | +118.4% | 214,157 | +113.0% | 0.02% | +155.6% |
Q2 2022 | $918,000 | -32.3% | 100,548 | -9.9% | 0.01% | -25.0% |
Q1 2022 | $1,356,000 | +742.2% | 111,592 | +744.0% | 0.01% | +1100.0% |
Q4 2021 | $161,000 | -31.2% | 13,222 | -12.7% | 0.00% | -50.0% |
Q3 2021 | $234,000 | – | 15,144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |